首页> 外国专利> PACKAGE OF TRANSDERMAL DRUG DELIVERY SYSTEM CONTAINING VARENICLINE OR PHARMACEUTICALLY ACCEPTABLE VARENICLINE ACID ADDITION SALT

PACKAGE OF TRANSDERMAL DRUG DELIVERY SYSTEM CONTAINING VARENICLINE OR PHARMACEUTICALLY ACCEPTABLE VARENICLINE ACID ADDITION SALT

机译:含凡士林或药物可接受的凡士林酸附加盐的经皮药物输送系统包装

摘要

PROBLEM TO BE SOLVED: To provide a transdermal drug delivery system containing varenicline or a pharmaceutically acceptable varenicline acid addition salt and being excellent in drug absorption and storage stability.;SOLUTION: A package of a transdermal drug delivery system reduced in the formation of a decomposition compound of drug varenicline and reduced especially, in the discoloration of a package with time, is provided by packaging a transdermal drug delivery system containing varenicline or a pharmaceutically acceptable salt of varenicline with an aluminum laminate sheet containing a polyacrylonitrile layer as the innermost layer.;COPYRIGHT: (C)2011,JPO&INPIT
机译:要解决的问题:提供一种包含伐尼克兰或药学上可接受的伐尼克兰酸加成盐的透皮给药系统,其药物吸收和储存稳定性极佳。;解决方案:一种经皮给药系统的包装,减少了分解的形成伐尼克兰的药物组合物,尤其是在包装的褪色中,是通过将包含伐尼克兰或伐尼克兰的可药用盐的透皮给药系统与包含聚丙烯腈层作为最内层的铝层压片包装在一起而减少的。版权所有:(C)2011,日本特许厅和INPIT

著录项

  • 公开/公告号JP2010285415A

    专利类型

  • 公开/公告日2010-12-24

    原文格式PDF

  • 申请/专利权人 HISAMITSU PHARMACEUT CO INC;

    申请/专利号JP20090160222

  • 申请日2009-06-15

  • 分类号A61K31/4985;A61K9/70;A61K47/32;A61K47/34;A61P25/34;A61J1/10;A61K47/38;A61K47/02;A61K47/04;

  • 国家 JP

  • 入库时间 2022-08-21 18:20:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号